SCHEMBL5326622

SCHEMBL5326622

Cc1cc(C(=O)O)ccc1NS(=O)(=O)c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.61
ALDH1A1 P00352 4/20 0.57
GAA P10253 3/20 0.57
HTT P42858 2/20 0.57
CASP3 P42574 1/20 0.57
SENP8 Q96LD8 1/20 0.57
SENP7 Q9BQF6 1/20 0.57
SENP6 Q9GZR1 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.56
KDM4E B2RXH2 1/20 0.55
TSHR P16473 1/20 0.55
PTK2B Q14289 1/20 0.55
HSD17B10 Q99714 3/20 0.53
KMT2A Q03164 2/20 0.53
CYTH2 Q99418 2/20 0.53
HPGD P15428 2/20 0.52
MEN1 O00255 1/20 0.52
ALOX15 P16050 1/20 0.52
SLC16A3 O15427 1/20 0.52
MCL1 Q07820 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17331322 0.88 CYP2C9 (0.60) METAP2ALDH1A1GAAHTTCASP3
SCHEMBL27884389 0.84 CYP2C9 (0.63) ALDH1A1GAAHTTKDM4ETSHR
SCHEMBL7372057 0.81 KDM4E (0.64) ALDH1A1HTTCASP3SENP8SENP7
SCHEMBL578654 0.81 FFAR4 (0.68) METAP2ALDH1A1GAAHTTL3MBTL1
SCHEMBL29472171 0.81 MCL1 (0.57) METAP2ALDH1A1GAAHTTTSHR
SCHEMBL28805203 0.81 L3MBTL1 (0.55) ALDH1A1GAAHTTL3MBTL1KDM4E
SCHEMBL5329433 0.81 NEU3 (0.60) ALDH1A1L3MBTL1KDM4ETSHRHSD17B10
SCHEMBL2896693 0.81 CYP2C9 (0.60) ALDH1A1GAAKDM4ETSHRHSD17B10
SCHEMBL4955646 0.80 CYTH2 (0.64) METAP2ALDH1A1GAAHTTKDM4E
SCHEMBL3724899 0.79 FABP4 (0.59) ALDH1A1KDM4ETSHRPTK2BHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007144379-A1 BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS MEDIVIR AB (SE) 2007-12-21 WO disclosed
WO-2007144379-A1 BICYCLIC COMPOUNDS USEFUL AS CATHEPSIN S INBHIBITORS MEDIVIR AB (SE) 2007-12-21 WO disclosed
CN-1149869-A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity MERCK & CO LTD (US) 1997-05-14 CN disclosed